Medication and Supplement Decisions After Genetic Testing
Why a genomic report should start a clinical conversation—not trigger self-directed medication changes.
By Kure Health Clinical Education Team · Reviewed September 22, 2026
Short answer
Do not change a medication or supplement from a genomic result alone. The significance of a variant depends on the drug, dose, other genes, health status, interactions, and the quality of evidence.
Pharmacogenomics has boundaries
Some gene–drug relationships have established clinical guidance; many wellness-oriented associations do not. A clinician should distinguish validated guidance from early or indirect evidence.
Bring the complete list
Review prescriptions, over-the-counter medicines, supplements, allergies, prior reactions, kidney and liver function, and the clinician managing each treatment.
What this means at Kure
AgeCode is one layer of Signal-Based Medicine. We review inherited architecture and methylation patterns alongside current symptoms, history, medications, standard laboratory findings, and other diagnostics. A report supports a clinical conversation; it does not make the decision alone.
Educational information only. Genomic and epigenetic associations do not diagnose disease or guarantee an outcome. Do not change medication or treatment without a qualified clinician.